For Epigenetics Research, are you looking at collaborating with Pharma Companies?

With the recent advances in the application of epigenetics in drug discovery, disease diagnosis, nutrition and lifestyle, it is a topic of interest for all leading pharma companies and research institutes.
The Epigenetics Discovery Congress to be held in London on the 24 - 25 September 2015 will focus on the following areas of Epigenetics :
  • Latest update on the clinical trials of epigenetic drugs
  • Drug discovery in epigenetics with case studies
  • Epigenetic biomarkers
  • Models and mechanisms of epigenetic gene regulation
  • Inter - individual variation and inheritance of epigenetic states in mammals
  • Epigenetics in disease diagnosis and treatment
  • Epigenetic drift in ageing
Speaker Presentations by
  • GlaxoSmithKline (GSK)
  • Cellzome
  • Oryzon
  • Epizyme
  • Novartis
  • Erasmus University Rotterdams
  • Cancer Research UK
  • Celgene
  • SGC
  • The Babraham Institute
  • Cambridge Biomedical Centre
  • University of Oxford
  • Blizard Institute
  • Volition Rx

The Epigenetics Discovery Congress will provide a platform to meet with over 150 UK and International delegates working in the field of Epigenetics. Register today with 'MnM-EDC30' as your discount code to get an early bird discount of 15% on registration fees; offer expires 30th June 2015.

We look forward to welcoming you in September.
Warm Regards,

Oliver Smith
Marketing Manager | MnM Conferences
P.S : Please forward this to any colleagues who you feel may be interested in the congress.